These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1899653)

  • 1. Immunolocalization of tissue plasminogen activator in the diabetic and nondiabetic retina and choroid.
    Lutty GA; Ikeda K; Chandler C; McLeod DS
    Invest Ophthalmol Vis Sci; 1991 Feb; 32(2):237-45. PubMed ID: 1899653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy.
    Mathews MK; Merges C; McLeod DS; Lutty GA
    Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2729-41. PubMed ID: 9418725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.
    Amin RH; Frank RN; Kennedy A; Eliott D; Puklin JE; Abrams GW
    Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):36-47. PubMed ID: 9008628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of antiapoptotic and proapoptotic molecules in diabetic retinas.
    Abu El-Asrar AM; Dralands L; Missotten L; Geboes K
    Eye (Lond); 2007 Feb; 21(2):238-45. PubMed ID: 16424911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey.
    Witmer AN; Blaauwgeers HG; Weich HA; Alitalo K; Vrensen GF; Schlingemann RO
    Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):849-57. PubMed ID: 11867607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of apoptosis markers in the retinas of human subjects with diabetes.
    Abu-El-Asrar AM; Dralands L; Missotten L; Al-Jadaan IA; Geboes K
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2760-6. PubMed ID: 15277502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressed expression of tubedown-1 in retinal neovascularization of proliferative diabetic retinopathy.
    Gendron RL; Good WV; Adams LC; Paradis H
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):3000-7. PubMed ID: 11687548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Occurrence of changes in the eye in diabetic retinopathy with significant myopia].
    Dujić M; Misailović K; Nikolić Lj; Ignjacev M
    Srp Arh Celok Lek; 1998; 126(11-12):457-60. PubMed ID: 9921019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor-1 overexpression in nonproliferative diabetic retinopathy.
    Grant MB; Ellis EA; Caballero S; Mames RN
    Exp Eye Res; 1996 Sep; 63(3):233-44. PubMed ID: 8943696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue plasminogen activator (tPA) activity is a novel and early marker of asymptomatic LEAD in type 2 diabetes.
    Sahli D; Eriksson JW; Boman K; Svensson MK
    Thromb Res; 2009 Mar; 123(5):701-6. PubMed ID: 18945481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group.
    Barber AJ; Antonetti DA; Gardner TW
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3561-8. PubMed ID: 11006253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of vascular endothelial growth factor in human retina and choroid.
    Lutty GA; McLeod DS; Merges C; Diggs A; Plouét J
    Arch Ophthalmol; 1996 Aug; 114(8):971-7. PubMed ID: 8694733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibronectin overexpression in retinal microvessels of patients with diabetes.
    Roy S; Cagliero E; Lorenzi M
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):258-66. PubMed ID: 8603829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type 1 diabetic patients.
    Iorio A; Federici MO; Mourvaki E; Ferolla P; Piroddi M; Stabile A; Timi A; Celleno R; Benedetti MM
    Thromb Haemost; 2007 Sep; 98(3):635-41. PubMed ID: 17849053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy.
    Bursell SE; Clermont AC; Kinsley BT; Simonson DC; Aiello LM; Wolpert HA
    Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):886-97. PubMed ID: 8603873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of Danshen injection on the reserve of tissue plasminogen activator and nitric oxide in endothelium and vasodilatation in diabetic patients].
    Zhang M; Li X; Qin G; Liu Y; Zhao X
    Zhong Yao Cai; 2005 Jun; 28(6):529-32. PubMed ID: 16209274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of simvastatin on hemostatic and fibrinolytic regulators in Type 2 diabetes mellitus.
    Ludwig S; Dharmalingam S; Erickson-Nesmith S; Ren S; Zhu F; Ma GM; Zhao R; Fenton JW; Ofosu FA; Velthuis HT; van Mierlo G; Shen GX
    Diabetes Res Clin Pract; 2005 Nov; 70(2):110-8. PubMed ID: 16188573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microvascular tissue plasminogen activator is reduced in diabetic neuropathy.
    Hafer-Macko CE; Ivey FM; Sorkin JD; Macko RF
    Neurology; 2007 Jul; 69(3):268-74. PubMed ID: 17636064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal capillary pericyte apoptosis in early human diabetic retinopathy.
    Li W; Yanoff M; Liu X; Ye X
    Chin Med J (Engl); 1997 Sep; 110(9):659-63. PubMed ID: 9642318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of the atrial natriuretic peptide/natriuretic peptide receptor-C system in the early stages of diabetic retinopathy in the rat.
    Rollín R; Mediero A; Fernández-Cruz A; Fernández-Durango R
    Mol Vis; 2005 Mar; 11():216-24. PubMed ID: 15789000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.